Navigation Links
InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)
Date:4/24/2009

- Results inform selection of doses, regimens to be explored in Phase 2b study -

-- Phase 2b program anticipated to begin in summer 2009 --

COPENHAGEN, April 24 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that results from a 14-day Phase 1b clinical study of ITMN-191 (R7227) in combination with the current standard of care were presented today by Stefan Zeuzem, M.D., of the J.W. Goethe University, Frankfurt, Germany, in an oral presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) in Copenhagen, Denmark. The study explored the use of ITMN-191 in combination with Pegasys(R) (peginterferon alfa-2a) and Copegus(R) (ribavirin) for 14 days of treatment in hepatitis C virus (HCV) treatment-naive patients infected with HCV genotype 1. ITMN-191 is an HCV protease inhibitor being developed in collaboration with Roche.

Among the highlights of his presentation, Dr. Zeuzem reported:

  • The combination of ITMN-191 plus the standard of care for 14 days resulted in rapid and sustained reductions in HCV RNA.
  • Substantial antiviral activity was observed in both the q8h and q12h dosing cohorts; the most rapid declines in HCV RNA occurred in the ITMN-191 900 mg q12h dosing cohort.
  • Viral rebound was not observed in any patient receiving treatment with ITMN-191 plus Pegasys and ribavirin.
  • ITMN-191 plus standard-of-care therapy was safe and generally well tolerated.
  • The findings support the continued evaluation of ITMN-191-based combination regimens of twice-daily and three-times-daily dosing in patients with chronic HCV infection.

Dr. Zeuzem, protocol chair of the study, said, "Based on the t
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Animal Health ... About Animal Health Animal health refers ... or treat animals to enhance their quality of ... of animal food. The Global Animal Health market ...
(Date:8/27/2014)... 2014 Sihuan Pharmaceutical Holdings Group Ltd. ... leading pharmaceutical company with the largest cardio-cerebral vascular ... prescription drug market, today announced the unaudited ... (collectively the "Group") for the six months ended ... HighlightsFor the Six months ended 30 JuneKey Income ...
(Date:8/27/2014)... , Aug. 27, 2014 ... research report is available in its ... for Application and Approval of Imported ... Practices (2014 Edition) ... Now, Chinese regulations on medical ...
Breaking Medicine Technology:Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... 10 Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), ... the treatment of cancer and,hepatitis C virus (HCV) ... protocol with the Drug Controller General of India ... efficacy trial of bavituximab in combination,with the chemotherapy ...
... Results in 2.7 log10 (>99%) Mean HCV RNA Decrease with No ... Serious Adverse Events - ... 8:30AM (ET) Today -, PRINCETON, N.J., Sept. 10 Pharmasset, Inc.,(Nasdaq: ... of monotherapy in 40 patients chronically,infected with hepatitis C virus (HCV) who have ...
Cached Medicine Technology:Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 2R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 3R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 4R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 5R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 6
(Date:8/28/2014)... 2014 The Foundation for Women’s ... in September by alerting women to the link between ... the symptoms of endometrial cancer. , Endometrial cancer ... most common cancer. More than 52,600 will learn of ... for women with weight management challenges to know the ...
(Date:8/28/2014)... PA (PRWEB) August 28, 2014 ... one of its clients, an inventor from California, has ... abdominal area. This invention is patented. , The “Abdominal ... to minimize the risk of injuries from physical activity ... due to surgery or muscular atrophy. Ideal for ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Altec ... and workflow solutions, announced today that they have ... the SoCal Chapter of the International Association of ... Services. IAMCP was founded in 1994, providing Microsoft ... and the IT community at large while facilitating ...
(Date:8/28/2014)... Dr. Stewart Shofner of ... the summer that recently headed off to college. According ... over 22 million students will attend college or university ... time attending classes, studying for exams, participate in sports ... eye problems. , Dr. Stewart Shofner shares five ...
(Date:8/28/2014)... Lauderdale, Fla. (PRWEB) August 28, 2014 A ... about the possibility of suicide contagion as a result of ... headlines, there is an increased risk of ‘copycat suicides’ among ... that the focus should not be on what happened—the suicide ... that lead to suicide. , “Suicide is a tragedy ...
Breaking Medicine News(10 mins):Health News:Foundation for Women's Cancer Alerts Women to Link Between Obesity and Endometrial Cancer 2Health News:InventHelp® Client Patents “Abdominal Swimming Support” – Invention Could Serve as an Alternative Flotation Device 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 2Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 3Health News:Sylvia Brafman Mental Health Center Warns of Suicide Contagion Following Robin Williams’ Death 2
... discovered by researchers at the University of North Carolina at ... forms of pancreatic cancer//, according to a study by an ... discovered six years ago by Dr. Carol Otey and her ... Brigham and Women’s Hospital in Boston. Otey has shown that ...
... An index comprising of the basic symptoms associated with ... its early stages, according to a new study.// This ... screening tool. ,The details of this study ... CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer ...
... H5N1 Outbreak as the Flu killed thousands of quails at a ... quails died over the weekend at a farm in Kimje, 262 ... have begun to cull the quails in the farm of the ... the third case since November 23 starting with an first outbreak ...
... Queensland (Australia) government has decided //to toughen its laws on ... cars carrying children. This comes in the wake of ... age, dies every 18 days, when exposed to cigarette smoke. ... of Queenslanders Report, 2006, made these comments. ,A ...
... Washington University School of Medicine have found out that successful ... dependence in many smokers. This study published in the December ... to look at smoking relapse among people who were "forced" ... has found that close to half of 154 smokers who ...
... face any kind of unforeseen pandemic, the province of Ontario ... disease control.// The officials, plan to form the centre on ... situated in Atlanta, U.S. ,Canadian media, quoting government ... intends to initiate proceedings to frame legislation, on the 12th ...
Cached Medicine News:Health News:Gene Discovered by Researchers Tied to Pancreatic Cancer 2Health News:A Basic Symptom Index For Early Detection Of Ovarian Cancer 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 3
... aqueous samples of moderate viscosity and density. Proven ergonomic design reduces hand ... Volume Range (ul) ... 2~5 Imprecision(%) ... 0.01 ...
... offers improved ergonomics for today's exacting ... grippy finger rest and the large ... efficiency. Finnpipette Digitals also feature soft-touch ... (pat. pend.) and super blow-out for ...
... Ultra is a fully adjustable, air-displacement pipette ... is the latest member of the Pipetman ... robustness, accuracy, and precision. We also added ... from our customers. Eight models cover the ...
Developed specifically for the 5000/5500 ultrasound consoles....
Medicine Products: